Funding will support a Phase 2b trial of phage therapy for chronic Pseudomonas aeruginosa lung infections.
Site Search
Showing 1 - 4 of 4 results
News
|
|
2 min read
This year’s program marked the largest in-person advocacy event in the Foundation’s history.
News
|
|
3 min read
The additional funding will support a Phase 2 clinical trial for an inhaled antisense oligonucleotide drug for people with cystic fibrosis who have the splicing mutation 3849+10Kb C-to-T.
Press Release
|
|
3 min read
Revised approach to lung function reporting is shown to be more scientifically accurate and may reduce health disparities.
News
|
|
5 min read